Phase I Oncology Drug Development

Phase I Oncology Drug Development
Author :
Publisher : Springer Nature
Total Pages : 352
Release :
ISBN-10 : 9783030476823
ISBN-13 : 3030476820
Rating : 4/5 (820 Downloads)

Book Synopsis Phase I Oncology Drug Development by : Timothy A. Yap

Download or read book Phase I Oncology Drug Development written by Timothy A. Yap and published by Springer Nature. This book was released on 2020-09-16 with total page 352 pages. Available in PDF, EPUB and Kindle. Book excerpt: This book provides a detailed review of how oncology drug development has changed over the past decade, and serves as a comprehensive guide for the practicalities in setting up phase I trials. The book covers strategies to accelerate the development of novel antitumor compounds from the laboratory to clinical trials and beyond through the use of innovative mechanism-of-action pharmacodynamic biomarkers and pharmacokinetic studies. The reader will learn about all aspects of modern phase I trial designs, including the incorporation of precision medicine strategies, and approaches for rational patient allocation to novel anticancer therapies. Circulating biomarkers to assess mechanisms of response and resistance are changing the way we are assessing patient selection and are also covered in this book. The development of the different classes of antitumor agents are discussed, including chemotherapy, molecularly targeted agents, immunotherapies and also radiotherapy. The authors also discuss the lessons that the oncology field has learnt from the development of hematology-oncology drugs and how such strategies can be carried over into therapies for solid tumors. There is a dedicated chapter that covers the specialized statistical approaches necessary for phase I trial designs, including novel Bayesian strategies for dose escalation. This volume is designed to help clinicians better understand phase I clinical trials, but would also be of use to translational researchers (MDs and PhDs), and drug developers from academia and industry interested in cancer drug development. It could also be of use to phase I trial study coordinators, oncology nurses and advanced practice providers. Other health professionals interested in the treatment of cancer will also find this book of great value.


Phase I Oncology Drug Development Related Books

Phase I Oncology Drug Development
Language: en
Pages: 352
Authors: Timothy A. Yap
Categories: Medical
Type: BOOK - Published: 2020-09-16 - Publisher: Springer Nature

DOWNLOAD EBOOK

This book provides a detailed review of how oncology drug development has changed over the past decade, and serves as a comprehensive guide for the practicaliti
The Drug Development Paradigm in Oncology
Language: en
Pages: 145
Authors: National Academies of Sciences, Engineering, and Medicine
Categories: Medical
Type: BOOK - Published: 2018-02-12 - Publisher: National Academies Press

DOWNLOAD EBOOK

Advances in cancer research have led to an improved understanding of the molecular mechanisms underpinning the development of cancer and how the immune system r
Novel Designs of Early Phase Trials for Cancer Therapeutics
Language: en
Pages: 234
Authors: Shivaani Kummar
Categories: Medical
Type: BOOK - Published: 2018-05-22 - Publisher: Academic Press

DOWNLOAD EBOOK

Novel Designs of Early Phase Trials for Cancer Therapeutics provides a comprehensive review by leaders in the field of the process of drug development, the inte
Anticancer Drug Development Guide
Language: en
Pages: 315
Authors: Beverly A. Teicher
Categories: Medical
Type: BOOK - Published: 2013-11-11 - Publisher: Springer Science & Business Media

DOWNLOAD EBOOK

Experienced cancer researchers from pharmaceutical companies, government laboratories, and academia comprehensively review and describe the arduous process of c
Phase I Cancer Clinical Trials
Language: en
Pages: 352
Authors: Elizabeth A. Eisenhauer
Categories: Medical
Type: BOOK - Published: 2015-03-20 - Publisher: Oxford University Press

DOWNLOAD EBOOK

Phase I trials are a critical first step in the study of novel cancer therapeutic approaches. Their primary goals are to identify the recommended dose, schedule